Global Clinical Trial Market is projected to reach USD 62.5 Billion by 2025, at a CAGR of 5.7% During Forecast Period| Ozone Market Reports
Clinical trials, research studies performed on
humans, are designed to gain specific information about biomedical
interventions such as vaccines, treatments and drugs in order to prove the
safety and efficacy of the products.
The Clinical Trial Market
accounted for USD 43.7 Billion in 2018 and is projected to
reach USD 62.5 Billion by 2025, at a CAGR of 5.7% over
the forecast period.
The driving factor of Clinical Trial Market
is globalization of clinical trials, development of new treatments such as
personalized medicine, augmenting evolution in technology, and boosting demand
for CROs to conduct clinical trials.
To Browse Complete report visit @ https://www.ozonemarketreports.com/pharmaceuticals-and-healthcare/global-clinical-trial-market-research-report/26981
Globalization of clinical trial has led to increase
in investment in new product development in emerging countries thereby, having
a positive impact on overall market. The availability of the vast array of
services from drug discovery to post-marketing surveillance has further
simplified the life for mid-size and small-scale pharmaceutical and
biotechnological organizations by providing them the option to outsource what
they think is beyond their core expertise. For instance, Pfizer currently has
three CROs working with it to enhance its product portfolio and drive
innovation. According to the partnership agreement with ICON in 2011, Pfizer
would only preserve the scientific ownership for the trials and studies
conducted by ICON, hence allowing the company to focus and further develop its
capabilities in clinical trial designing.
By region, North America has dominated the
Clinical Trial Market and has generated USD XX million market value in 2017 and
is estimated to reach USD XX million market by 2025 with growing XX% CAGR. The
region has dominated the market as it has presence of big outsourcing firms and
increasing R&D in the region.
The major participants in the global Clinical Trial
Market include Quintiles IMS, Paraxel International Corporation, Charles River
Laboratories, ICON plc, SGS SA, Chiltern, Omnicare, PPD, Kendle and
others.
Market Segmentation:
Clinical Trial Market is segmented based on Phase, Design, Indication
and geography.
Market segmented by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market segmented by Design
- Treatment Studies
- Randomized Control Trial
- Adaptive Clinical TrialNon-Randomized Control
Trial
- Observational Studies
- Cohort Study
- Case Control Study
- Cross Sectional Study
- Ecological Study
- Expanded Access
To Get Free
Sample Request Report visit @ https://www.ozonemarketreports.com/sample-request/global-clinical-trial-market-research-report/26981
Market segmented by Indication
- Autoimmune/inflammation
- Pain management
- Oncology
- CNS condition
- Diabetes
- Obesity
- Cardiovascular
Market segmented by region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Key Players
- Quintiles IMS
- Paraxel International Corporation
- Charles River Laboratories
- ICON plc
- SGS SA
- Chiltern
- Omnicare
- PPD
- Kendle
To
Browse Similar Reports: https://www.ozonemarketreports.com/category/pharmaceuticals-and-healthcare/11